November 2, 2009
The Second Pan Asian-Pacific ESC Symposium – Moving Towards a Global Approach to Cardiovascular Disease Management will be held on 27th November at three venues across China.
June 7, 2009
Results from the Action in Diabetes and Vascular Disease: preterAx and diamicroN-MR Controlled Evaluation (ADVANCE) study (1) show that, among patients with type 2 diabetes, those who have atrial fibrillation (AF) are at higher risk of death from any cause, cardiovascular death, major cerebrovascular events and heart failure compared to those without AF. The absolute benefit of lowering blood pressure is therefore greater among patients with both diabetes and AF.
Log in or Register now.
Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.